Publications & News – PhageNova Bio

Publications

Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain
Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates
Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity.
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector.
Tumor vasculature-targeted delivery of tumor necrosis factor-alpha.
A hybrid vector for ligand-directed tumor targeting and molecular imaging.
A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.
AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.
Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc. 2007.
Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU. Nat Protoc. 2007.
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011.
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. Proc Natl Acad Sci USA 2016.
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer. Proc Natl Acad Sci USA 2016.
An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications. Cancer Gene Ther. 2017.